Literature DB >> 2562069

Phaeohyphomycosis due to Phialophora richardsiae.

M Tam, S Freeman.   

Abstract

Phaeohyphomycosis, an infection characterised by dematiaceous yeast-like cells, hyphae and pseudohyphae in tissue, is an uncommon condition, often affecting immunosuppressed patients. A sixty four year old boat-builder, receiving treatment with prednisone and azathioprine developed multiple cutaneous nodules on the extremities. Histology showed a mixed dermal inflammatory infiltrate with scattered spores and hyphae. Culture revealed two organisms, Phialophora richardsiae and Exophiala jeanselmei. Fluorocytosine was initially given but the organism was found to be resistant. Since side effects have been associated with long term ketoconazole therapy, a less toxic and more potent triazole compound, itraconazole, was used. After three months, the lesions had completely resolved without adverse clinical or biochemical changes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2562069     DOI: 10.1111/j.1440-0960.1989.tb00406.x

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN: 0004-8380            Impact factor:   2.875


  3 in total

1.  Pleurostomophora richardsiae - an insidious fungus presenting in a man 44 years after initial inoculation: A case report and review of the literature.

Authors:  Jeremy S Levenstadt; Susan M Poutanen; Subhash Mohan; Sean Zhang; Michael Silverman
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

2.  Hepatic phaeohyphomycosis due to a novel dematiaceous fungus, Pleurostoma hongkongense sp. nov., and importance of antifungal susceptibility testing.

Authors:  Chi-Ching Tsang; Ka-Fai Chan; Walton Chan; Jasper F W Chan; Rex K H Au-Yeung; Antonio H Y Ngan; Ken P K Lin; Susanna K P Lau; Patrick C Y Woo
Journal:  Emerg Microbes Infect       Date:  2021-12       Impact factor: 7.163

3.  Subcutaneous phaeohyphomycosis caused by Pleurostomophora richardsiae in a renal transplant recipient.

Authors:  Louis Y Tee; Ban Hock Tan; Ai-Ling Tan; Inny Busmanis; Choon Chiat Oh
Journal:  JAAD Case Rep       Date:  2019-12-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.